News

This Hamilton-built AI could change how lung cancer is diagnosed in Canada
With survival rates still low, NodeAI’s deep-learning tool could double the accuracy of a crucial cancer test — and cut costs ...
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results
When the patient opted against surveillance CT scans and a follow-up PET scan, her physician ordered the CyPath® Lung test in March 2025. The test result of 0.56 – classified as “likely malignancy” – ...